ATE417856T1 - Motilidverbindungen - Google Patents

Motilidverbindungen

Info

Publication number
ATE417856T1
ATE417856T1 AT03755757T AT03755757T ATE417856T1 AT E417856 T1 ATE417856 T1 AT E417856T1 AT 03755757 T AT03755757 T AT 03755757T AT 03755757 T AT03755757 T AT 03755757T AT E417856 T1 ATE417856 T1 AT E417856T1
Authority
AT
Austria
Prior art keywords
sup
motilide
compounds
motilide compounds
diseases
Prior art date
Application number
AT03755757T
Other languages
English (en)
Inventor
Daniel Santi
Brian Metcalf
Christopher Carreras
Yaoquan Liu
Robert Mcdaniel
Eduardo Rodriguez
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE417856T1 publication Critical patent/ATE417856T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT03755757T 2002-08-29 2003-08-26 Motilidverbindungen ATE417856T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40734502P 2002-08-29 2002-08-29

Publications (1)

Publication Number Publication Date
ATE417856T1 true ATE417856T1 (de) 2009-01-15

Family

ID=31978464

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03755757T ATE417856T1 (de) 2002-08-29 2003-08-26 Motilidverbindungen

Country Status (15)

Country Link
US (1) US6946482B2 (de)
EP (1) EP1532131B1 (de)
JP (1) JP4796300B2 (de)
KR (1) KR101051613B1 (de)
CN (1) CN100363359C (de)
AT (1) ATE417856T1 (de)
AU (1) AU2003273254B2 (de)
CA (1) CA2492846C (de)
CY (1) CY1108808T1 (de)
DE (1) DE60325377D1 (de)
DK (1) DK1532131T3 (de)
ES (1) ES2316805T3 (de)
PT (1) PT1532131E (de)
SI (1) SI1532131T1 (de)
WO (1) WO2004019879A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8063021B2 (en) 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
US7407941B2 (en) * 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
GB0327720D0 (en) * 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
US7211568B2 (en) * 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
CN101203227B (zh) * 2005-05-24 2011-01-12 辉瑞大药厂 促动内酯类化合物
US20070135362A1 (en) * 2005-12-08 2007-06-14 Yaoquan Liu Method for demethylating the 3'-dimethylamino group of erythromycin compounds
EP2431380A3 (de) 2006-09-11 2013-07-03 Tranzyme Pharma, Inc. Makrozyklischer Antagonist des Motilinrezeptors zur Behandlung von Magen-Darm-Motilitätsstörungen
RU2422453C2 (ru) 2006-12-05 2011-06-27 Пфайзер Инк. Полиморфы мотилида
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
CN106138038B (zh) * 2015-04-28 2021-04-20 天津国际生物医药联合研究院 大环内酯类衍生物及其用途
CN106478541A (zh) * 2016-10-17 2017-03-08 南开大学 大环内酯类衍生物及其用途
CN106478542A (zh) * 2016-10-17 2017-03-08 南开大学 一种大环内脂类衍生物盐、其制备方法及用途

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US391594A (en) * 1888-10-23 Arc-extinguisher for electric switches or cut-outs
US4382086A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
PL136968B1 (en) 1983-02-10 1986-04-30 Tarchominskie Zaklad Farma Process for preparing cyclic 11,12-carbonate of erythromycin a
JPS60218321A (ja) * 1984-04-13 1985-11-01 Satoshi Omura 消化管収縮運動促進剤
EP0184921A3 (de) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycinderivate
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
US4857641A (en) * 1987-08-14 1989-08-15 Pfizer Inc. C.12 modified erythromycin A derivatives
IL93936A (en) * 1989-03-28 1994-06-24 Abbott Lab History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them
US5190871A (en) * 1989-06-12 1993-03-02 Eli Lilly And Company Use of the site-specific integrating function of phage φC31
US5824513A (en) * 1991-01-17 1998-10-20 Abbott Laboratories Recombinant DNA method for producing erythromycin analogs
US5554605A (en) * 1991-04-09 1996-09-10 Abbott Laboratories Macrocyclic lactam prokinetic agents
AU663089B2 (en) * 1991-04-09 1995-09-28 Abbott Laboratories Macrocyclic lactam prokinetic agents
CA2125478A1 (en) * 1992-01-21 1993-07-22 Paul A. Lartey 4"-deoxyerythromycin derivatives
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
US6066721A (en) * 1995-07-06 2000-05-23 Stanford University Method to produce novel polyketides
US5712146A (en) * 1993-09-20 1998-01-27 The Leland Stanford Junior University Recombinant combinatorial genetic library for the production of novel polyketides
EP0836649B1 (de) * 1995-07-06 2004-12-29 The Leland Stanford Junior University Zellfreie synthese von polyketiden
US6077943A (en) * 1996-03-01 2000-06-20 Takeda Chemical Industries, Ltd. Method of producing erythromycin derivative
WO1997035590A1 (en) * 1996-03-25 1997-10-02 Platt Chris E 10-aza-9-deoxo-11-deoxy-erythromycin a and derivatives combined with sulfisoxazole
US5712253A (en) * 1996-06-18 1998-01-27 Abbott Laboratories Macrocyclic 13-membered ring derivatives of erythromycins A and B
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
US5922849A (en) * 1996-11-22 1999-07-13 Abbott Laboratories Process for preparation of N-demethyl-4"-deoxy-erthromycins A and B
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU9645998A (en) 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU9646098A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6084079A (en) * 1998-05-15 2000-07-04 Keyes; Robert F. Process for preparing N-demethyl-N-alkyl erythromycin derivatives
WO2000024907A2 (en) * 1998-10-28 2000-05-04 Kosan Biosciences, Inc. Library of novel "unnatural" natural products
CA2347412A1 (en) * 1998-10-29 2000-05-11 Kosan Biosciences, Inc. Recombinant oleandolide polyketide synthase
WO2000044717A2 (en) 1999-01-27 2000-08-03 Kosan Biosciences, Inc. Synthesis of oligoketides
AU775637B2 (en) * 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6524841B1 (en) 1999-10-08 2003-02-25 Kosan Biosciences, Inc. Recombinant megalomicin biosynthetic genes and uses thereof
JP2003512073A (ja) 1999-10-27 2003-04-02 コーサン バイオサイエンシーズ, インコーポレイテッド ポリケチドの異種産生
AU2001238476A1 (en) * 2000-02-18 2001-08-27 Kosan Biosciences, Inc. Motocide compounds
US6838265B2 (en) * 2000-05-02 2005-01-04 Kosan Biosciences, Inc. Overproduction hosts for biosynthesis of polyketides
WO2002051855A2 (en) * 2000-12-01 2002-07-04 Kosan Biosciences, Inc. Motilide compounds
US20020094962A1 (en) * 2000-12-01 2002-07-18 Gary Ashley Motilide compounds
EP1365726A2 (de) * 2001-02-15 2003-12-03 Kosan Biosciences, Inc. Verfahern zur beurteilung der therapeutischen wirksamkeit
JP4509553B2 (ja) * 2001-07-03 2010-07-21 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド 抗菌活性を有するc12修飾エリスロマイシンマクロライドおよびケトライド
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.

Also Published As

Publication number Publication date
CN100363359C (zh) 2008-01-23
CN1665799A (zh) 2005-09-07
AU2003273254A1 (en) 2004-03-19
CA2492846A1 (en) 2004-03-11
WO2004019879A2 (en) 2004-03-11
CY1108808T1 (el) 2014-04-09
US6946482B2 (en) 2005-09-20
JP2005537317A (ja) 2005-12-08
EP1532131A2 (de) 2005-05-25
EP1532131B1 (de) 2008-12-17
KR20050038594A (ko) 2005-04-27
DE60325377D1 (de) 2009-01-29
DK1532131T3 (da) 2009-02-09
SI1532131T1 (sl) 2009-04-30
EP1532131A4 (de) 2007-05-30
ES2316805T3 (es) 2009-04-16
CA2492846C (en) 2012-09-25
WO2004019879A3 (en) 2004-06-03
US20040138150A1 (en) 2004-07-15
PT1532131E (pt) 2009-02-18
WO2004019879A8 (en) 2004-07-29
JP4796300B2 (ja) 2011-10-19
KR101051613B1 (ko) 2011-07-25
AU2003273254B2 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
CY1108808T1 (el) Ενωσεις μοτιλιδης
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
BR0307432B1 (pt) difluormetiltiazolilcarboxanilidas
TW200509892A (en) Novel aminobenzophenone compounds
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
BR0315644A (pt) Piperazinil e diazapanil benzamidas e benzotioamidas
SE0302139D0 (sv) Novel compounds
TW200630374A (en) Thiazolyldihydroindazoles
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
SE0003476D0 (sv) Compounds
ATE265455T1 (de) Tetrahydropyridoverbindungen
NO20054361D0 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
BR0311386A (pt) Furancarboxamidas
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
DE50311756D1 (de) Mikrobizide oxathiincarboxamide
CY1105345T1 (el) Φαινυλαλκινια
CY1106711T1 (el) Υποκατεστημενα παραγωγα προπανο-1,3-διαμινης και η φαρμακευτικη χρηση τους
GB0309440D0 (en) Quinolone derivatives
NO20053562L (no) Nye aminobenzofenonforbindelser
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1532131

Country of ref document: EP